Evidence map›Paper›PMID 31282100›Full record

ArticleCNS neuroscience & therapeutics2020

Exposure to recurrent hypoglycemia alters hippocampal metabolism in treated streptozotocin-induced diabetic rats.

Neelesh Dewan, Vibha Shukla, Ashish K Rehni, Kevin B Koronowski, Kyle D Klingbeil, Holly Stradecki-Cohan, Timothy J Garrett, Tatjana Rundek, Miguel A Perez-Pinzon, Kunjan R Dave

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. The cognitive consequences of hypoglycemia in diabetes.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  2. Article
  3. Strategies for optimization of hypoglycemia rat models.Animal models and experimental medicine · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Neelesh DewanPeritz Scheinberg Cerebral Vascular Disease Research Laboratories, University of Miami School of Medicine, Miami, Florida, USA.
Vibha ShuklaPeritz Scheinberg Cerebral Vascular Disease Research Laboratories, University of Miami School of Medicine, Miami, Florida, USA.
Ashish K RehniPeritz Scheinberg Cerebral Vascular Disease Research Laboratories, University of Miami School of Medicine, Miami, Florida, USA.
Kevin B KoronowskiPeritz Scheinberg Cerebral Vascular Disease Research Laboratories, University of Miami School of Medicine, Miami, Florida, USA.
Kyle D KlingbeilPeritz Scheinberg Cerebral Vascular Disease Research Laboratories, University of Miami School of Medicine, Miami, Florida, USA.
Holly Stradecki-CohanPeritz Scheinberg Cerebral Vascular Disease Research Laboratories, University of Miami School of Medicine, Miami, Florida, USA.
Timothy J GarrettSoutheast Center for Integrated Metabolomics, Clinical and Translational Science Institute, University of Florida, Gainesville, Florida, USA.
Tatjana RundekDepartment of Neurology, University of Miami School of Medicine, Miami, Florida, USA.
Miguel A Perez-PinzonPeritz Scheinberg Cerebral Vascular Disease Research Laboratories, University of Miami School of Medicine, Miami, Florida, USA.
Kunjan R DavePeritz Scheinberg Cerebral Vascular Disease Research Laboratories, University of Miami School of Medicine, Miami, Florida, USA.ORCID 0000-0002-0173-5338
University of Miami · USUniversity of Florida · US

Funding

Southeast Resource Center for Integrated Metabolomics (SECIM)U24DK097209 · NIDDK · UNIVERSITY OF FLORIDA · PI EDISON, ARTHUR S, YOST, RICHARD A. · 2013 to 2017
$9.2M
Increased cerebral ischemic injury by repeated hypoglycemic episodes in diabetesR01NS073779 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DAVE, KUNJAN R · 2012 to 2016
$1.5M
NIDDK NIH HHS U24 DK097209NINDS NIH HHS R01 NS073779
6 · The paper itself

Abstract

aimsExposure to recurrent hypoglycemia (RH) is common in diabetic patients receiving glucose-lowering therapies and is implicated in causing cognitive impairments. Despite the significant effect of RH on hippocampal function, the underlying mechanisms are currently unknown. Our goal was to determine the effect of RH exposure on hippocampal metabolism in treated streptozotocin-diabetic rats.

methodsHyperglycemia was corrected by insulin pellet implantation. Insulin-treated diabetic (ITD) rats were exposed to mild/moderate RH once a day for 5 consecutive days.

resultsThe effect of RH on hippocampal metabolism revealed 65 significantly altered metabolites in the RH group compared with controls. Several significant differences in metabolite levels belonging to major pathways (eg, Krebs cycle, gluconeogenesis, and amino acid metabolism) were discovered in RH-exposed ITD rats when compared to a control group. Key glycolytic enzymes including hexokinase, phosphofructokinase, and pyruvate kinase were affected by RH exposure.

conclusionOur results demonstrate that the exposure to RH leads to metabolomics alterations in the hippocampus of insulin-treated streptozotocin-diabetic rats. Understanding how RH affects hippocampal metabolism may help attenuate the adverse effects of RH on hippocampal functions.

Indexed as

AnimalsBlood GlucoseCognition DisordersDiabetes Mellitus, ExperimentalGlycolysisHippocampusHypoglycemiaHypoglycemic AgentsInsulinMaleMetabolic Networks and PathwaysMetabolomeRatsRats, WistarRecurrenceBlood GlucoseHypoglycemic AgentsInsulindiabetesenzyme kineticsglycolysishippocampusmetabolomics

Identifiers

PMID31282100
PMCPMC6930817
OpenAlexW2962483860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.